Many medications can help increase your body’s insulin production. These may include amylin mimetics, incretin mimetics, dipeptidyl-peptidase 4 inhibitors, sulfonylureas, linides, and more.

Insulin is a hormone released by the pancreas when you eat food, allowing sugar to move from the blood into the cells where it’s used for energy. If the cells of the body are not using insulin well or the body is unable to make enough insulin, glucose can build up in the blood.

This can lead to insulin resistance, prediabetes, and diabetes. Whether you’ve been diagnosed with a type of diabetes or your healthcare team recommends the need for improved insulin production, there are medications that can help raise the body’s insulin levels.

Numerous classes of medications can help increase insulin production in people with diabetes.

Most of these medications are effective in treating type 2 diabetes. People with this form of diabetes still have the ability to produce insulin, so they often respond better to treatment.

Some of these medications may be used along with insulin injections to manage blood glucose levels in people with type 1 diabetes, who no longer produce insulin in their bodies and must take it another way.

Amylin mimetics

Amylin mimetics are injectable drugs that mimic the hormone amylin your body naturally produces. Amylin mimetics work in your body just like amylin.

They stop your body from secreting glucagon, help you feel fuller, and slow down how quickly food leaves your stomach. These medications are used in combination with injectable insulin. They’re used when symptoms of type 1 diabetes do not improve with insulin injections alone.

An example of this type of medication is pramlintide (SymlinPen).

Incretin mimetics

Incretin mimetics are another class of injectable insulin-increasing drugs. They’re often prescribed along with other types of medication to help manage glucose levels.

People taking these medications are sometimes encouraged to also eat a more balanced diet and exercise more frequently.

Types of incretin mimetics include:

  • generic exenatide (formerly sold as Byetta or Bydureon, but now discontinued)
  • liraglutide (Victoza)
  • semaglutide (Ozempic)
  • dulaglutide (Trulicity)

Dipeptidyl-peptidase 4 inhibitors

Dipeptidyl peptidase 4 inhibitors (DPP-4s) are oral pills that increase the release of insulin from the pancreas, according to 2021 research. They also reduce the release of glucose from the liver.

These drugs are often combined with other types of medications to treat people with type 2 diabetes.

Examples of DPP-4s include:

Sulfonylureas

Sulfonylureas are an older class of medication used to treat people with diabetes. They’re usually given orally to those who are unable to manage their blood glucose levels through diet and exercise.

They work by increasing the release of insulin from the pancreas to reduce blood glucose levels.

Examples of sulfonylureas include:

Glinides

Glinides are oral insulin-increasing drugs given to people with type 2 diabetes.

Also known as meglitinides, these medications usually take effect more quickly than other options. However, they do not last long and need to be taken multiple times per day.

They’re often prescribed alongside another medication, especially if symptoms do not improve with diet and lifestyle changes.

Examples of glinides include:

Managing your diabetes

There many ways to manage diabetes and help improve how insulin works in your body. Your doctor can also help discuss any blood sugar management and concerns you may have about insulin.

Everyone’s body is different, so you may respond differently to medication than others with the same type of diabetes.

Talk with your doctor about your treatment options so they can help you find medication and lifestyle modifications that work best for you.

SOURCES:

Alexopoulos A-S, et al. (2019). Triglycerides: Emerging targets in diabetes care? Review of moderate hypertriglyceridemia in diabetes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664805/

Costello RA, et al. (2022). Sulfonylureas. https://www.ncbi.nlm.nih.gov/books/NBK513225/

Erzen S, et al. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. https://pmc.ncbi.nlm.nih.gov/articles/PMC10855385/

Feingold, KR. (2022). Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes. https://www.ncbi.nlm.nih.gov/books/NBK279141/

Kasina SVSK, et al. (2022). Dipeptidyl peptidase IV (DPP IV) inhibitors. https://www.ncbi.nlm.nih.gov/books/NBK542331/

Medication for type 2 diabetes. InformedHealth.org. (2020). https://www.ncbi.nlm.nih.gov/books/NBK279506/